stars 1 stars 2 stars 3

Founded in 2013, Sonostics, Inc. focuses on the non-invasive, non-pharmacologic treatment of secondary heart failure, which results in the pooling of fluids in the lower body and reduced venous return to the heart. Extensive research and ten years of clinical studies conducted by MIT graduate Dr. Kenneth McLeod, Ph.D. led to the creation of the innovative HeartPartner. The HeartPartner is unique in that it exercises your secondary heart muscles — the soleus muscles in your lower legs — to improve conditions caused by poor circulation. Acting as the “pacemaker for your secondary hearts”, the HeartPartner's targeted vibration technology works to reduce lower limb fluid pooling that can cause symptoms such as chronic fatigue, dizziness, blurred vision, cognitive dysfunction, as well as swelling of the legs and feet and varicose veins.

Sonostics Questions

The Sonostics annual revenue was $400000 in 2026.

Sonostics is based in Endicott, New York.

The NAICS codes for Sonostics are [334, 33].

The SIC codes for Sonostics are [384, 38].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users